Analyst: US gastroenterology ASC market to hit $10.8B

The U.S. gastroenterology-facing ASC market will hit $10.8 billion by 2026, according to a Grand View Research market report.

What you should know:

1. The market was valued at $6.9 billion in 2018 and is projected to grow at a 5.91 percent compound annual growth rate from that time.

2. Analysts attributed the growth to cost efficiency, improved patient outcomes, disease prevalence, a growing geriatric population and the convenience of ASCs.

3. Analysts also said the industrywide shift to outpatient settings was a reason the market has been so attractive. The U.S. has approximately 9,280 ASCs, with the highest concentrations in California, Florida and Texas.

More articles on surgery centers: 
Nevada city drops ASC building acquisition to let health system buy it
Insights from the CEOs of Optum, USPI, Surgery Partners & more — 8 ASC industry notes
Why Texas' ASC market is booming — 4 center leaders elaborate

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months